Latest news

Insights

Top 10 Strategic Priorities for Pharmaceutical Leaders in 2026

Executive Summary The pharmaceutical industry is entering a period of profound transformation. While scientific innovation remains the foundation of long-term...
Insights

Why Data Quality Is Becoming Pharma’s Biggest AI Challenge

Executive Summary Artificial intelligence (AI) has become one of the pharmaceutical industry's most important strategic priorities. Companies are investing heavily in...
Commercial

Lilly challenges J&J in the market for psychedelic mental health by paying $2.8 billion up front for AtaiBeckley

Eli Lilly has inked the deal to purchase AtaiBeckley for $2.8 billion to continue its acquisition spree in a...
Insights

The Next Wave of Innovation in Oncology

Executive Summary Oncology remains one of the most dynamic and rapidly evolving areas of pharmaceutical innovation. Over the past two decades,...
Clinical

Hansoh Announces Fresh Phase 3 Victory For Priority ADC

Hansoh Pharmaceutical has recorded another late-stage success for its...
Clinical

Altimmune Reports Phase 2 Pemvidutide Results in Alcohol Use Disorder

Altimmune has reported topline results from its Phase 2...
Commercial

Included Health Agrees to Acquire Firefly Health to Expand Employer Health Plan Alternatives

Virtual care and health navigation company Included Health has agreed to acquire Firefly Health as it seeks to scale...
Insights

The Workforce Challenge Facing Biopharma Manufacturing

Executive Summary Biopharmaceutical manufacturing is entering one of the most important periods of transformation in its history. Demand for advanced therapies,...
Commercial

Argenx purchases Forte for $2.2 billion to enter the hands-on phase two-stage medication for vitiligo

Forte Biosciences is being acquired by Argenx for $2.2 billion in a deal that has two stages: phase 2...
Insights

What Pharma Leaders Are Prioritizing in 2026

Executive Summary The pharmaceutical industry is entering a new phase...
Regulatory

Takeda’s Qdenga Makes History as First Vaccine to Get the Nod in India

Takeda has secured approval from the Drug Controller General...
Commercial

Tempus purchases a specialist in cancer genomics in a $1.5 billion deal: Personalis

Since the two first joined forces in oncology three years ago, Tempus is expanding its cancer programs with plans...
Insights

How RNA Therapeutics Are Expanding Beyond Rare Diseases

Executive Summary RNA therapeutics have emerged as one of the most significant innovations in modern medicine. Initially developed to address rare...
Commercial

Samsung Biologics Plans $1.8 Billion Acquisition of PolyPeptide

Samsung Biologics has announced plans to acquire Swiss contract development and manufacturing organization (CDMO) PolyPeptide in a transaction valued...
Regulatory

Takeda’s Qdenga Makes History as First Vaccine to Get the Nod in India

Takeda has secured approval from the Drug Controller General...
Editorial Team -
Commercial

Agreement for the commercialization of mammography AI reached between iCAD and Google Health

A deal was penned between medical tech company iCAD...
Commercial

Keebler Raises $16 Million Series A to Advance AI-Based Risk Adjustment Platform

Artificial intelligence startup Keebler Health has secured $16 million...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

The U.S. Food and Drug Administration (FDA) granted Johnson & Johnson De Novo clearance...
Editorial Team -

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Alnylam has entered into a partnership with the scientist instrumental in developing the technology...
Editorial Team -

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team -

J&J MedTech presents the first Ottava surgical robot clinical cases

Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...
Editorial Team -

Regulatory

Regulatory

Takeda’s Qdenga Makes History as First Vaccine to Get the Nod in India

Takeda has secured approval from the Drug Controller General...
Editorial Team -
Insights

Why Data Quality Is Becoming Pharma’s Biggest AI Challenge

Executive Summary Artificial intelligence (AI) has become one of the...
Commercial

Lilly challenges J&J in the market for psychedelic mental health by paying $2.8 billion up front for AtaiBeckley

Eli Lilly has inked the deal to purchase AtaiBeckley...
Insights

The Next Wave of Innovation in Oncology

Executive Summary Oncology remains one of the most dynamic and...
Commercial

GSK will increase its R&D efforts by investing £400 million in Britain over three years

British pharmaceutical and biotechnology firm GSK has announced a...

Research & Development

Market Access

Manufacturing

Avalyn Files for IPO Targeting Up to $209.7 Million to Advance Inhaled Lung Therapies

Avalyn Pharma, a Boston-based company focused on inhaled therapies...
Manufacturing

Replimune Cuts 224 Jobs in Massachusetts After Second FDA Rejection of RP1

Replimune is reducing its workforce by 224 employees across...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Insights

Top 10 Strategic Priorities for Pharmaceutical Leaders in 2026

Executive Summary The pharmaceutical industry is entering a period of...
Editorial Team -